Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.

A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Abstract Text:

    s s c chanS S C Chan,w h tamW H Tam,w yeoW Yeo,m m y yuM M Y Yu,d p s ngD P S Ng,a w y wongA W Y Wong,w h kwanW H Kwan,p m yuenP M Yuen,s s c chanS S C Chan,w h tamW H Tam,w yeoW Yeo,m m y yuM M Y Yu,d p s ngD P S Ng,a w y wongA W Y Wong,w h kwanW H Kwan,p m yuenP M Yuen,

    OBJECTIVE: To study the prophylactic use of levonorgestrel intrauterine system (LNG-IUS) in the prevention of endometrial pathology in women having breast cancer treated with tamoxifen. DESIGN: Randomised controlled trial. SETTING: A tertiary teaching hospital. POPULATION: One hundred and thirteen women (66 premenopausal/47 postmenopausal) who required adjuvant tamoxifen for breast cancer after the completion of postoperative radiotherapy and chemotherapy. METHODS: Women were randomised to treatment group (prophylactic LNG-IUS insertion before the commencement of tamoxifen) or control group. Uterine cavity was examined by outpatient hysteroscopy and endometrial biopsy before and at 12 months after commencement of tamoxifen. MAIN OUTCOME MEASURES: De novo endometrial pathology at 1 year of tamoxifen. RESULTS: Women in the treatment group had a much lower incidence of endometrial polyp (1.8 versus 15.5%, P= 0.017) (relative risk: 0.12; 95% CI: 0.02-0.91) at 12 months. There was no significant difference in the incidence of submucosal fibroid between the two groups (1.8 versus 3.4%, P= 1.0). LNG-IUS was retained in 95% women in the treatment group at 1 year. CONCLUSION: LNG-IUS reduces the occurrence of de novo endometrial polyp in women treated with tamoxifen for breast cancer.

    A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Publishing Authors By Initials

    ss chanSS Chan,wh tamWH Tam,w yeoW Yeo,mm yuMM Yu,dp ngDP Ng,aw wongAW Wong,wh kwanWH Kwan,pm yuenPM Yuen,ss chanSS Chan,wh tamWH Tam,w yeoW Yeo,mm yuMM Yu,dp ngDP Ng,aw wongAW Wong,wh kwanWH Kwan,pm yuenPM Yuen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: BJOG : an international journal of obstetrics and

    VOLUME: 114

    Page Numbers: 1510-5

    Journal Abbreviation:

    ISSN: 1471-0528

    DAY: 12

    MONTH: Dec

    YEAR: 2007

    A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100935741

    A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.

    AFFILIATION: Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. symphorosa@cuhk.edu.hk

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: BJOG

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News